Congress Must Approve Changes to International Intellectual Property Rules (TRIPS).
This bill restricts the President's authority, preventing unilateral negotiation or modification of the international Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Any changes that could affect patents (e.g., on medicines) or copyrights will now require explicit authorization from Congress. This ensures that major shifts in US innovation and trade policy must undergo legislative debate and approval.
Key points
The President is prohibited from independently changing international patent and copyright rules (TRIPS Agreement).
Any negotiation to suspend or modify intellectual property rights must be explicitly authorized by Congress beforehand.
This change increases Congressional oversight over key aspects of US trade and innovation policy.
Expired
Citizen Poll